A review on the role of ADAMTS9-AS2 in different disorders.

[1]  Zhao Chen,et al.  ADAMTS9-AS2 regulates PPP1R12B by adsorbing miR-196b-5p and affects cell cycle-related signaling pathways inhibiting the malignant process of esophageal cancer , 2022, Cell cycle.

[2]  Yun Wu,et al.  ADAMTS9-AS2 Promotes Angiogenesis of Brain Microvascular Endothelial Cells Through Regulating miR-185-5p/IGFBP-2 Axis in Ischemic Stroke , 2022, Molecular Neurobiology.

[3]  R. Ramlau,et al.  A Signature of 14 Long Non-Coding RNAs (lncRNAs) as a Step towards Precision Diagnosis for NSCLC , 2022, Cancers.

[4]  Dongbing Li,et al.  LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma , 2021, International journal of general medicine.

[5]  A. Ebrahimi,et al.  Long non-coding RNA panel as a molecular biomarker in glioma , 2021, Journal of the Egyptian National Cancer Institute.

[6]  Wenguang Luo,et al.  Bioinformatics Analysis and Functional Verification of ADAMTS9-AS1/AS2 in Lung Adenocarcinoma , 2021, Frontiers in Oncology.

[7]  R. Abdul-Maksoud,et al.  The diagnostic significance of circulating lncRNA ADAMTS9‐AS2 tumor biomarker in non‐small cell lung cancer among the Egyptian population , 2021, The journal of gene medicine.

[8]  Liu Liu,et al.  Comprehensive analysis of differentially expressed genes in clinically diagnosed irreversible pulpitis by multi-platform data integration using a robust rank aggregation approach. , 2021, Journal of endodontics.

[9]  Yichun Zhu,et al.  The lncRNA ADAMTS9-AS2 Regulates RPL22 to Modulate TNBC Progression via Controlling the TGF-β Signaling Pathway , 2021, Frontiers in Oncology.

[10]  Yufeng Cheng,et al.  Screening of tumor grade‐related mRNAs and lncRNAs for Esophagus Squamous Cell Carcinoma , 2021, Journal of clinical laboratory analysis.

[11]  Zhihua Yin,et al.  The relationship between LncRNAs and lung adenocarcinoma as well as their ceRNA network. , 2021, Cancer biomarkers : section A of Disease markers.

[12]  Q. Lu,et al.  Long non-coding RNA ADAMTS9-AS2 inhibits liver cancer cell proliferation, migration and invasion , 2021, Experimental and therapeutic medicine.

[13]  Wen Xu,et al.  ADAMTS9-AS2: A functional long non-coding RNA in tumorigenesis. , 2021, Current pharmaceutical design.

[14]  E. Feingold,et al.  Assessment of genetic risk of type 2 diabetes among Pakistanis based on GWAS-implicated loci. , 2021, Gene.

[15]  Yongning Zhou,et al.  Construction of a novel ceRNA network and identification of lncRNA ADAMTS9-AS2 and PVT1 as hub regulators of miRNA and coding gene expression in gastric cancer , 2021, Translational cancer research.

[16]  Yi Dai,et al.  Long-Chain Noncoding RNA ADAMTS9-AS2 Regulates Proliferation, Migration, and Apoptosis in Bladder Cancer Cells Through Regulating miR-182-5p. , 2021, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[17]  M. Taheri,et al.  The emerging role of non-coding RNAs in the regulation of PI3K/AKT pathway in the carcinogenesis process. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  Qiuyun Chen,et al.  Transcriptome Sequencing reveals the expressed profiles of mRNA and ncRNAs and regulate network via ceRNA mediated molecular mechanism of lung adenocarcinoma bone metastasis in Xuanwei , 2021, Translational cancer research.

[19]  Zhi-jing He,et al.  Exosome‐derived long non‐coding RNA ADAMTS9‐AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway , 2020, Journal of cellular and molecular medicine.

[20]  A. Sayad,et al.  Regulatory role of microRNAs on PTEN signaling. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[21]  F. Zhou,et al.  ADAMTS9-AS2 and CADM2 expression and association with the prognosis in esophageal squamous cell carcinoma. , 2020, Biomarkers in medicine.

[22]  Gang Liu,et al.  Long Noncoding RNA ADAMTS9-AS2 Inhibits the Proliferation, Migration, and Invasion in Bladder Tumor Cells , 2020, OncoTargets and therapy.

[23]  D. Piao,et al.  LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis , 2020, Aging.

[24]  M. Taheri,et al.  The HOTTIP (HOXA transcript at the distal tip) lncRNA: Review of oncogenic roles in human. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  Feiran Wang,et al.  LncRNA ADAMTS9‐AS2 suppresses the proliferation of gastric cancer cells and the tumorigenicity of cancer stem cells through regulating SPOP , 2020, Journal of cellular and molecular medicine.

[26]  Peng Zhang,et al.  Identification of Three lncRNAs as Potential Predictive Biomarkers of Lung Adenocarcinoma , 2020, BioMed research international.

[27]  L. Rainbow,et al.  Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis , 2020, British Journal of Cancer.

[28]  X. Gou,et al.  Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma , 2019, Cancer Cell International.

[29]  Weidong Zhu,et al.  Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels , 2019, International journal of molecular sciences.

[30]  Yang Yang,et al.  Long noncoding RNA ADAMTS9‐AS2 suppresses the progression of esophageal cancer by mediating CDH3 promoter methylation , 2019, Molecular carcinogenesis.

[31]  Dazhi Xu,et al.  Construction of a Competitive Endogenous RNA Network and Identification of Potential Regulatory Axis in Gastric Cancer , 2019, Front. Oncol..

[32]  Lunquan Sun,et al.  Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis , 2019, Front. Cell Dev. Biol..

[33]  M. Taheri,et al.  Taurine‐upregulated gene 1: A functional long noncoding RNA in tumorigenesis , 2019, Journal of cellular physiology.

[34]  Xin Ma,et al.  LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis , 2019, Aging.

[35]  Zhangru Yang,et al.  Identification and development of long non‐coding RNA‐associated regulatory network in colorectal cancer , 2019, Journal of cellular and molecular medicine.

[36]  C. Pan,et al.  LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[37]  A. Pandey,et al.  Identification of lncRNAs associated with early‐stage breast cancer and their prognostic implications , 2019, bioRxiv.

[38]  Hb Wang,et al.  Downregulated lncRNA ADAMTS9-AS2 in breast cancer enhances tamoxifen resistance by activating microRNA-130a-5p. , 2019, European review for medical and pharmacological sciences.

[39]  Tie-su Lin,et al.  Robust analysis of novel mRNA–lncRNA cross talk based on ceRNA hypothesis uncovers carcinogenic mechanism and promotes diagnostic accuracy in esophageal cancer , 2018, Cancer management and research.

[40]  Hanyu Ma,et al.  Upregulation of lncRNA ADAMTS9-AS2 Promotes Salivary Adenoid Cystic Carcinoma Metastasis via PI3K/Akt and MEK/Erk Signaling. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[41]  Lei Li,et al.  LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway. , 2018, International journal of biological macromolecules.

[42]  Zuozhang Yang,et al.  Upregulated lncRNA ADAMTS9‐AS2 suppresses progression of lung cancer through inhibition of miR‐223‐3p and promotion of TGFBR3 , 2018, IUBMB life.

[43]  Y. Bao,et al.  CDKAL1 rs7756992 is associated with diabetic retinopathy in a Chinese population with type 2 diabetes , 2017, Scientific Reports.

[44]  Jian Zhang,et al.  A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells , 2014, Tumor Biology.

[45]  W. Almawi,et al.  A replication study of 19 GWAS-validated type 2 diabetes at-risk variants in the Lebanese population. , 2013, Diabetes research and clinical practice.

[46]  Yeqing Huang,et al.  ADAMTS9-AS2: a potential diagnostic and prognostic hallmark in prostate cancer. , 2021, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[47]  S. Hou,et al.  Differentially expressed long non-coding RNAs and the prognostic potential in colorectal cancer. , 2016, Neoplasma.